-
Product Insights
NewLikelihood of Approval Analysis for Friedreich Ataxia
Overview How likely is it that the drugs in Friedreich Ataxia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Friedreich Ataxia Overview Friedreich’s ataxia (FA) is a neuromuscular disease that mainly...
-
Product Insights
FAS-Kulachi Solar PV Park
FAS-Kulachi Solar PV Park is a solar PV project located in Khyber Pakhtunkhwa, Pakistan. The project is owned and being developed by FAS Energy. The project is at the permitting stage. Empower your strategies with our FAS-Kulachi Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of...
-
Product Insights
Benban Fas Energy Solar PV Park
Benban Fas Energy Solar PV Park is a solar PV project located in Aswan, Egypt. The project is owned by FAS Energy and was developed by FAS Energy; GE Renewable Energy. The project came online in 2019. Empower your strategies with our Benban Fas Energy Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the...
-
Company Insights
Innovation and Patenting activity of Chico~s FAS Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Chico~s FAS Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Thematic Analysis
Apparel M&A Deals 2023 – Top Themes – Thematic Intelligence
This report analyzes the disruptive themes that have driven M&A activity in 2023 in the Apparel Sector
-
Thematic Analysis
Retail M&A Deals 2023 – Top Themes – Thematic Intelligence
This report analyzes the disruptive themes that have driven M&A activity in 2023 in the Retail Sector
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PA-5108 in Open-Angle Glaucoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PA-5108 in Open-Angle Glaucoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PA-5108 in Open-Angle Glaucoma Drug Details: PA-5108 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AB-1015 in Fallopian Tube Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.AB-1015 in Fallopian Tube Cancer Drug Details:AB-1015 is under development for the treatment of ovarian cancer,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AB-1015 in Peritoneal Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.AB-1015 in Peritoneal Cancer Drug Details:AB-1015 is under development for the treatment of ovarian cancer, fallopian...